Equest And Equest Pramox STILL The ONLY Choices For Single Dose Control Of Encysted Small Redworm
9 years ago 
1390 views
Zoetis is reminding vets and SQPs to ensure they stock the appropriate wormers to treat for encysted small redworm this autumn/winter. Moxidectin is the only licensed active for single dose control of encysted small redworm and is contained in only two products – Equest and Equest Pramox.
All horses should receive a treatment effective against encysted small redworm during the late autumn/ early winter, even if they have a low or negative faecal worm egg count.1,2 However, last year’s National Equine Health Survey3, revealed that one in five owners who claimed to have treated for encysted small redworm used a wormer containing an active that was not indicated to treat these potentially lethal encysted parasites. This may leave horses at serious risk.
Encysted small redworm are one of the most common and harmful types of worm found in horses. They are the larval stages of the small redworm that have buried into the lining of the gut where they can lie dormant for some time. They pose a potentially fatal health risk but won’t show up in a standard faecal worm egg count. Untreated, encysted small redworm may develop and emerge en masse from the gut wall in the early spring, causing diarrhoea and colic with a mortality rate of up to 50%.4
Equest and Equest Pramox are the only products available to treat for encysted small redworm in a single dose. Equest is an oral gel containing moxidectin for single dose control of roundworms - including encysted larval stages of small redworms, and bots. Equest Pramox is an oral gel containing moxidectin and praziquantel for single dose control of all three species of tapeworm, roundworms - including encysted larval stages of small redworms, and bots.
Equest and Equest Pramox are licensed for use in breeding, pregnant and lactating mares and have been shown not to adversely affect the fertility of mares.5,6 Equest and Equest Pramox are available in 700kg syringes and have the longest dosing interval (13 weeks) of any equine wormer currently available.
Speak to your Zoetis Account Manager to find out more. Further information is available from your medicines provider or Zoetis UK Ltd.,?Walton Oaks, Dorking Road, Walton-on- the-Hill, Tadworth, Surrey KT20 7NS Customer Support: 0845 3008034 www.zoetis.co.uk.
EQUEST and EQUEST PRAMOX are registered trademarks of Zoetis UK Ltd. EQUEST contains moxidectin and EQUEST PRAMOX contains moxidectin and praziquantel. EQUITAPE contains praziquantel. Advice on the use of these or alternative treatments must be sought from the medicine prescriber POM-VPS. Further information from Zoetis UK Ltd, Walton Oaks, Dorking Road, Walton-on-the-Hill, Tadworth, Surrey KT20 7NS
Use medicines responsibly www.noah.co.uk/responsible
References
1. Nielsen (2012) Veterinary Paristology. 185. 32-44
2. J Matthews 2008
3. The National Equine Health Survey, conducted by the Blue Cross and supported by Zoetis, was completed by 3,669 horse owners in May 2014. The survey contained 25 questions on general horse health, care and management and was validated by Professor Josh Slater of the Royal Veterinary College.
4. Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225?242
5. EQUEST 18.92 mg/g Oral Gel (moxidectin) Data Sheet, February 2014
6. EQUEST PRAMOX Oral Gel (moxidectin & praziquantel) Data Sheet, February 2014
More from Zoetis
- Zoetis appoints new Inside Sales Account Manager
- Zoetis Equip® Artervac Supply Issue
- Zoetis UK Appoints Simon Dunne as Companion Animal Business Unit Director
- Zoetis UK: Update On The Supply Of Equip® Rotavirus
- Zoetis UK and StreetVet Announce Charity of the Year Partnership to Further Support the Human Animal Bond
